Effect of the Semiconductor Quantum Dot Shell Structure on Fluorescence Quenching by Acridine Ligand


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The main line of research in cancer treatment is the development of methods for early diagnosis and targeted drug delivery to cancer cells. Fluorescent semiconductor core/shell nanocrystals of quantum dots (e.g., CdSe/ZnS) conjugated with an anticancer drug, e.g., an acridine derivative, allow real-time tracking and control of the process of the drug delivery to tumors. However, linking of acridine derivatives to a quantum dot can be accompanied by quantum dot fluorescence quenching caused by electron transfer from the quantum dot to the organic molecule. In this work, it has been shown that the structure of the shell of the quantum dot plays the decisive role in the process of photoinduced charge transfer from the quantum dot to the acridine ligand, which is responsible for fluorescence quenching. It has been shown that multicomponent ZnS/CdS/ZnS shells of CdSe cores of quantum dots, which have a relatively small thickness, make it possible to significantly suppress a decrease in the quantum yield of fluorescence of quantum dots as compared to both the classical ZnS thin shell and superthick shells of the same composition. Thus, core/multicomponent shell CdSe/ZnS/CdS/ZnS quantum dots can be used as optimal fluorescent probes for the development of systems for diagnosis and treatment of cancer with the use of anticancer compounds based on acridine derivatives.

About the authors

P. A. Linkov

National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Laboratory of Research in Nanosciences, LRN—EA4682

Author for correspondence.
Email: valinkov@gmail.com
Russian Federation, Moscow, 115409; Reims, 51100

K. V. Vokhmintcev

National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)

Email: valinkov@gmail.com
Russian Federation, Moscow, 115409

P. S. Samokhvalov

National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)

Email: valinkov@gmail.com
Russian Federation, Moscow, 115409

M. Laronze-Cochard

Institute of Molecular Chemistry of Reims, Faculty of Pharmacy

Email: valinkov@gmail.com
France, Reims, 51100

J. Sapi

Institute of Molecular Chemistry of Reims, Faculty of Pharmacy

Email: valinkov@gmail.com
France, Reims, 51100

I. R. Nabiev

National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Laboratory of Research in Nanosciences, LRN—EA4682

Email: valinkov@gmail.com
Russian Federation, Moscow, 115409; Reims, 51100

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Inc.